PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
85.51%
Net income growth above 1.5x MRVL's 26.04%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
29.38%
D&A growth well above MRVL's 6.11%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
91.86%
Slight usage while MRVL is negative at -326.47%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
41.22%
Some inventory rise while MRVL is negative at -92.36%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
482.80%
Some yoy usage while MRVL is negative at -136.43%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
4013.65%
Some yoy increase while MRVL is negative at -19.55%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
22750.46%
Some CFO growth while MRVL is negative at -6.50%. John Neff would note a short-term liquidity lead over the competitor.
-27.89%
Both yoy lines negative, with MRVL at -119.78%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-72.79%
Both yoy lines negative, with MRVL at -4531.20%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-11.00%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-482.88%
Both yoy lines negative, with MRVL at -2096.48%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
5.83%
Stock issuance far above MRVL's 11.35%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.